The Realm of Noncoding RNAs | GenomeWeb

The Realm of Noncoding RNAs

Premium

For decades, a biologist could think of a gene as a protein-coding piece of the genome. There were exceptions, although these noncoding genes encoded RNA that tended to have housekeeping or structural roles. It was obvious that the non-protein products were important for the cell, but it was hard — for some of us, anyway — to imagine these RNAs playing many cool regulatory roles in processes like development or the progression of disease. As a result, we could concentrate on protein-coding genes when compiling gene sets, designing microarrays, and doing other large-scale biology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.